Emerging biopharma companies consistently underinvest in communications until they need it urgently — ahead of a financing round, a regulatory milestone, a partnership announcement, or a crisis. Building credibility with investors, media, and key opinion leaders takes time. It cannot be assembled in three weeks before a roadshow.
Katogen Operations provides strategic communications support designed for the pace and constraints of emerging biopharma. We develop the corporate narrative, build the media relationships, manage the content calendar, and prepare your leadership to deliver the right message in every setting — from investor meetings to industry conferences to employee all-hands.
We keep communications strategies grounded in what actually drives business outcomes: investor confidence, partner credibility, and talent attraction.
Capabilities — What We Cover
Corporate narrative and key message development
Storyline development for clinical/regulatory milestones, partnerships, M&A, and leadership changes
Press release drafting and wire distribution management
Proactive media relations: trade outlets, industry podcasts, financial press
Media monitoring: competitor share of voice, trend stories, owned placements
LinkedIn and social media strategy: corporate and senior executive accounts
Investor presentation development and polish
Message rehearsal and presentation training (1:1, in-person or virtual)
Crisis communications planning and response
Leadership transition communications
Internal communications and employee engagement campaigns
Event planning and execution: investor days, conferences, town halls
Why Katogen — Why Work With Us
Communications built around biopharma business milestones — not generic PR retainers.
Messaging integrated with Katogen Strategy — aligns with your financing narrative and investor positioning.
Senior communications leadership with deep healthcare industry experience.
Designed for lean teams: we act as your communications function, not an outside vendor.